Telix Pharmaceuticals axes $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share purchase plan